Literature DB >> 23827400

Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus.

Amy H Kao1, Apinya Lertratanakul, Jennifer R Elliott, Abdus Sattar, Linda Santelices, Penny Shaw, Mehret Birru, Zheni Avram, Trina Thompson, Kim Sutton-Tyrrell, Rosalind Ramsey-Goldman, Susan Manzi.   

Abstract

Patients with systemic lupus erythematosus (SLE) are at increased risk for cardiovascular (CV) disease. The aim of this study was to investigate the association between subclinical CV disease as measured by carotid intima-media thickness (IMT) and plaque using B-mode carotid ultrasound and incident CV events in a combined cohort of female patients with SLE. This was a prospective, 2-center observational study of 392 adult women with SLE and no previous CV events with a mean 8 years of follow-up. Incident CV events confirmed by clinicians were defined as angina, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft, fatal cardiac arrest, transient ischemic attack, and cerebrovascular accident. Incident hard CV events excluded angina and transient ischemic attack. The mean age was 43.5 years, and most patients were Caucasian (77.3%). During follow-up, 38 patients had incident CV events, and 17 had incident hard CV events. Patients with incident hard CV events had higher mean carotid IMT (0.80 vs 0.64 mm, p <0.01) and presence of carotid plaque (76.5% vs 30.4%, p <0.01) compared with those without incident hard CV events. Baseline carotid IMT and presence of plaque were predictive of any incident hard CV event (hazard ratio 1.35, 95% confidence interval 1.12 to 1.64, and hazard ratio 4.26, 95% confidence interval 1.23 to 14.83, respectively), independent of traditional CV risk factors and medication use. In conclusion, in women with SLE without previous CV events, carotid IMT and plaque are predictive of future CV events. This suggests that carotid ultrasound may provide an additional tool for CV risk stratification in patients with SLE.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23827400      PMCID: PMC3779482          DOI: 10.1016/j.amjcard.2013.05.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

3.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

Authors:  L E Chambless; G Heiss; A R Folsom; W Rosamond; M Szklo; A R Sharrett; L X Clegg
Journal:  Am J Epidemiol       Date:  1997-09-15       Impact factor: 4.897

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS).

Authors:  Matthias W Lorenz; Stefan von Kegler; Helmuth Steinmetz; Hugh S Markus; Matthias Sitzer
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

6.  Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.

Authors:  M M Ward
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

7.  Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Authors:  Yu Asanuma; Annette Oeser; Ayumi K Shintani; Elizabeth Turner; Nancy Olsen; Sergio Fazio; MacRae F Linton; Paolo Raggi; C Michael Stein
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 8.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

9.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

10.  Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study.

Authors:  Laurence Fardet; Irene Petersen; Irwin Nazareth
Journal:  BMJ       Date:  2012-07-30
View more
  26 in total

1.  Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus.

Authors:  April Jorge; Apinya Lertratanakul; Jungwha Lee; William Pearce; David McPherson; Trina Thompson; Emma Barinas-Mitchell; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-21       Impact factor: 4.794

Review 2.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

Review 3.  Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.

Authors:  Christopher B Oliveira; Mariana J Kaplan
Journal:  Semin Immunopathol       Date:  2022-03-30       Impact factor: 11.759

Review 4.  Cardiovascular disease in systemic lupus erythematosus.

Authors:  Maureen McMahon; Richard Seto; Brian J Skaggs
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

5.  Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.

Authors:  Caroline Grönwall; Harmony Reynolds; June K Kim; Jill Buyon; Judith D Goldberg; Robert M Clancy; Gregg J Silverman
Journal:  Clin Immunol       Date:  2014-04-03       Impact factor: 3.969

6.  Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV.

Authors:  Sumbal A Janjua; Pedro V Staziaki; Balint Szilveszter; Richard A P Takx; Thomas Mayrhofer; Orla Hennessy; Hamed A Emami; Jakob Park; Alexander Ivanov; Travis R Hallett; Michael T Lu; Javier M Romero; Steven K Grinspoon; Udo Hoffmann; Markella V Zanni; Tomas G Neilan
Journal:  Circ Cardiovasc Imaging       Date:  2017-10       Impact factor: 7.792

7.  Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state.

Authors:  Elise Danielle McVeigh; Amna Batool; Arnold Stromberg; Ahmed Abdel-Latif; Nayef Mohammed Kazzaz
Journal:  Lupus Sci Med       Date:  2021-05

Review 8.  Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.

Authors:  Anselm Mak; Nien Yee Kow
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

9.  Asymptomatic Carotid Atherosclerosis Cardiovascular Risk Factors and Common Hypertriglyceridemia Genetic Variants in Patients with Systemic Erythematosus Lupus.

Authors:  Marta Fanlo-Maresma; Beatriz Candás-Estébanez; Virginia Esteve-Luque; Ariadna Padró-Miquel; Francesc Escrihuela-Vidal; Monica Carratini-Moraes; Emili Corbella; Xavier Corbella; Xavier Pintó
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

Review 10.  Elucidating the Intriguing Association Between Systemic Lupus Erythematosus and Cardiovascular Disease.

Authors:  Mushrin Malik; Rajvi Gor; Nabeel A Siddiqui; Dhairya Gor; Kazi I Ahmed
Journal:  Cureus       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.